Guillain Barre syndrome risk from H1N1 vaccine

H1N1 vaccine associated with small but significant risk of Guillain-Barre syndrome – Guillain-Barre syndrome (GBS) is usually characterized by rapidly developing motor weakness and areflexia (the absence of reflexes). “The disease is thought to be autoimmune and triggered by a stimulus of external origin.

Health Newstrack